"The discussion highlights a mixed sentiment towards $UNH, emphasizing that profits from pharmacy benefit management (PBM) will likely offset challenges in the insurance sector. Additionally, there is skepticism about Warren Buffett's limited investment in the company, suggesting that while $UNH is not a standout investment, it remains a viable option in the current market landscape."